Novel systemic therapy in advanced non-small-cell lung cancer
Standard chemotherapy regimes (platinum-based combinations) for advanced non-small-cell lung cancer have reached their therapeutic limits. In the last few years standard chemotherapy has been supplemented by targeted therapy. Targeted therapy consists of tyrosine kinase inhibitors (TKIs) against epi...
Main Authors: | Cristina Tiut, Christoph C Zielinski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Hamdan Medical Journal |
Online Access: | http://www.hamdanjournal.org/article.asp?issn=2227-2437;year=2016;volume=9;issue=1;spage=39;epage=56;aulast=Tiut;type=0 |
Similar Items
-
Recent advances of novel targeted therapy in non-small cell lung cancer
by: Li Zujun, et al.
Published: (2009-01-01) -
Advances of Maintenance Therapy on Advanced Non-Small Cell Lung Cancer
by: Aimi HUANG, et al.
Published: (2009-04-01) -
Advances of Targeted therapies in Non-small Cell Lung Cancer
by: Zhanque ZHANG, et al.
Published: (2009-12-01) -
Customizing systemic therapy in patients with advanced non-small cell lung cancer
by: A. M. Sadowska, et al.
Published: (2011-07-01) -
Advance of Postoperative Adjuvant Therapy in Non-small Cell Lung Cancer
by: Na HAN, et al.
Published: (2014-06-01)